Medical Communications

Showing 15 posts of 6402 posts found.

Matt Hancock

NHS to stockpile drugs in preparation for no-deal Brexit

July 25, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, brexit, government, pharma, stockpiling

Secretary of State for Health and Social Care, Matt Hancock, has said that the NHS is preparing to stockpile medicines …
stana-moisescu-appointment

Teva Romania announces new general manager

July 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Israeli multinational Teva Pharmaceuticals have announced the appointment of Stana Moisescu as the General Director of Teva Romania, the company’s …
512px-antibiotic_sensitvity_and_resistance

The mission against antimicrobial resistance

July 23, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance, antimicrobial resistance, feature, pharma

Two headlines have highlighted the ‘here and now’ of the threat of rising antimicrobial resistance (AMR), writes Dr Peter Jackson.A …
top_10_image

Top Ten most popular articles on Pharmafile.com this week

July 20, 2018 Medical Communications GSK, ICR, J&J, JJ, Novartis, Trump, brexit, top 10

As Brexit negotions have hit a stalemate this week, the United Kingdom’s exit from the European Union has hit the …
ki67-tubulin-2

Scottish borders-based Ryboquinn acquires viral delivery comany Nanogenics

July 20, 2018 Medical Communications M&A, MA, Scotland, acquisitions, gene therapy, nanogenics, ryboquinn

The Scottish biotech company Ryboquinn has acquired English partner Nanogenics Solutions in a deal worth £4.45 million. The Selkirk-based firm …
16792957331_d9572dbdf4_z

FDA explores import strategy in effort to reduce price of drugs

July 20, 2018 Medical Communications Drug pricing, Trump, borders, import, the donald

The FDA has been directed to explore ways in which medicines could be safely imported from other countries “in the …
merckwindow_web

Merck joins Pizer and Novartis in reducing drug prices

July 20, 2018 Medical Communications Merck, Novartis, Pfizer, Trump, Twitter, price hikes

Merck & Co. have joined Pfizer and Novartis in halting price increases on medicines in the United States. The American …
donald_trump_29496131773

Donald Trump thanks Novartis for halting price hikes

July 20, 2018 Medical Communications Novartis, Pfizer, Trump, Twitter, price hikes

Donald Trump has thanked Swiss multinational Novartis for halting price hikes on prescription drugs in the United States. The US …

Novartis buys eczema drug in €95m deal

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, deal, eczema, experimental, patent

Novartis has agreed to buy the rights for a novel antibody MOR106 from the Belgo-Dutch pharmaceutical research company Galapagos and …

PhRMA take on PBM’s in response to Trump drug price plan

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In response to Donald Trump’s plan to lower drug prices in the US, the Pharmaceutical Research and Manufacturers of America …
28246711066_52e38bc591_z

MPs vote to stay in EMA after Brexit

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, UK, brexit, parliament, vote

British MPs have voted for the UK’s continued participation in the regulatory network operated by the European Medicines Agency (EMA) …
800px-bill_og_melinda_gates_2009-06-03_bilde_01

Bill Gates commits $30m towards Alzheimer’s diagnostic test

July 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Bill Gates, billionaire, diagnosis

Microsoft business magnate Bill Gates has joined a coalition of philanthropists in committing more than $30 million towards the development …
david_horn_solomon

Silence Therapeutics appoints ex-Akari CEO in top position

July 17, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, CEO, Sanofi, Silence Therapeutics, zealand

Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head …
patient_graphic

Recruitment and retention: How can we do better?

July 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, feature, patient recruitment, patients, pharma

In pharma R&D, data is king, but consistent struggles with patient retention is undermining the integrity of clinical findings. Matt …
The Gateway to Local Adoption Series

Latest content